Early Access — free while we kick the tires
EdgarHawk

McKinley Kate

Chief Business Officer

Officer
1 filing analyzed · 1 company · Latest 2024-12-16

Companies

Company Buys Sells Direction
Rani Therapeutics Holdings, Inc. RANI 1 0 Net buying

Activity

December 2024
Buy
17,960 shares
$29,993
Significance 4/10

CBOwallace McKinley Kate buys 17,960 shares (18.0K) of RANI at $1.67; stock down -79.8% YTD, company burning cash with $-6.8M net loss.

McKinley Kate, Chief Business Officer, purchased 17,960 shares at $1.67 on 2024-12-13, establishing an initial position in RANI. The transaction occurs in severe fundamental distress: the company reported $0.00 revenue in the latest quarter, a net loss of $-6.8M, and experienced -100.0% annual revenue growth. The stock has collapsed -79.8% from its 52-week high of $7.85 and is down -30.0% over the preceding 30 days. An insider purchase by a senior executive in a revenue-depleted, loss-generating company trading at multi-year lows merits investor scrutiny of both the company's operational trajectory and the CBOs rationale for the investment at this valuation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access